Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
10.3389/fimmu.2019.02462 108
Reported effects Significant weight loss (1015% body weight reduction) Improved glycemic control Reduced appetite and food intake Potential cardiovascular benefits Convenient once-weekly dosing Reported side effects Nausea, vomiting, diarrhea, constipation, abdominal pain (most common, typically mild) Injection-site reactions (redness, swelling, irritation) Hypoglycemia (less common, mainly when combined with insulin/sulfonylureas) Rare serious risks: pancreatitis, gallbladder disease, acute kidney injury Storage Lyophilised (unmixed) Freeze at -20 C (-4 F) After reconstitution Refrigerate at 28 C (35.646.4 F) and use within 28 days Supplies Important notes Always use a new, sterile insulin syringe for each injection and dispose of it properly in a sharps container
In a study conducted in individuals with metabolic syndrome without diabetes or cerebrovascular event, liver enzymes and ultrasound improved during the study with the use of statins 37
A Category 1 listing only means a compound can be legally prepared by 503A compounding pharmacies it does not make BPC-157 an FDA-approved drug
US$ 29.73
US$ 24.94
US$ 26.62
US$ 23.59
US$ 25.07
